Vendor, Missoula, MT
Fyr Diagnostics Inc.
UEI FXC2KX47NS48, CAGE 8KXG5
1 award and $299,828 obligated between September 10, 2025 and September 3, 2026, 100% under full and open competition, against 55.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $299,828 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91025C00044Definitive Contract, September 10, 2025, Full and Open Competition After Exclusion of Sources, 55 offers | NIH NCINational Institutes of Health | Tumor-Derived Extracellular Vesicles for Diagnosis of Early-Stage Ovarian CancerNAICS 541714, PSC AN12 | $299,828 |
- Places of performance
- Montana
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 2 across 1 awards